Isothermal Nucleic Acid Amplification (Infectious Diseases, Blood Screening, Research) Technology (INAAT) Market - Global Forecast to 2018 - Hawaii News Now - KGMB and KHNL

Isothermal Nucleic Acid Amplification (Infectious Diseases, Blood Screening, Research) Technology (INAAT) Market - Global Forecast to 2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE Research and Markets

DUBLIN, June 5, 2014 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application, Products & End-User - Global Forecast to 2018" report to their offering.

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Despite the dominance of polymerase chain reaction (PCR) technology, INAAT is expected to seize a considerable market space in the global market since it enhances the quality of point-of-care testing using miniature DNA diagnostics.

Major driving factors of the global market includes increasing prevalence of infectious disease and cancer, promise for less expensive and better throughput in gene amplification using INAAT, and advent of novel technologies such as Loop-Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA) and Helicase Dependent Amplification (HDA). However, inadequate automation and portability, and high dominance of PCR technology restrict the adoption of isothermal amplification technology globally.

Reagent segment held the maximum share of 70% of the global market in 2013; the segment is expected to grow at 14.7% CAGR due to increasing consumption of reagents in the detection of chronic diseases and genetic disorders. Future scope of market development lies in less expensive and portable POCT device as well as real time Chip based Nucleic Acid Testing (NAT) for SNP genotyping and cancer. Currently, difficulties in developing lab-on-chip due to lack of multidisciplinary approach, and high entry barrier in PCR dominated emerging nations restrict the market momentum in the developing countries.

Infectious disease was found to be the highest revenue generating segment (57.2%) of the global isothermal nucleic acid amplification technology market in 2013; it is expected to grow at a double digit growth during the forecast period. It is primarily attributed to high incidence rate of various infectious diseases such as HIV and hepatitis A & B, and increasing importance of INAAT in infection detection globally.

Adoption of INAAT in blood screening application is also expected to grow as it ensures the quality of donated blood through its early prognosis of pathogen; whereas, cancer research, whole genome amplification, mutation, SNP detection and expression analysis are expected to drive the INAAT research application market.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Technology Landscape Analysis

4 Technology Investment Potential

5 Market Landscape Analysis

6 Product Market

7 Applications Market

8 End-User Market

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles

Companies Mentioned:

  • Alere
  • Becton, Dickinson and Company (Bd)
  • Biohelix
  • Biomerieux
  • Eiken Chemical Co., Ltd.
  • Hologic Gen-Probe
  • Lucigen
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • Novartis Diagnostics
  • Nugen
  • Qiagen
  • Ustar Biotechnologies

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

©2012 PR Newswire. All Rights Reserved.